 CARLSBAD, Calif., Jan. 24, 2023 GLOBE NEWSWIRE Qualigen Therapeutics, Inc. Qualigen or the Company, Nasdaq: QLGN, a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces the initiation of Good Laboratory Practice GLP toxicology studies of its lead... The post Qualigen Therapeutics Initiates Good Laboratory Practice GLP Toxicology Studies on... 